All relevant data are within the manuscript and its Supporting Information files.

Introduction {#sec001}
============

Cell differentiation, the building block of development, is a strong representation of regulatory precision. In stem cell differentiation, a handful of regulators kick off a regulatory mechanism that leads to the activation or repression of other regulators and non-regulatory genes, through consecutive waves, starting processes that are geared towards specification and giving rise to different kinds of cells and tissues \[[@pone.0231326.ref001]--[@pone.0231326.ref005]\]. The discovery of induced pluripotent stem cells (iPSCs) \[[@pone.0231326.ref006]--[@pone.0231326.ref008]\], opened the door to a rising number of cell differentiation experiments. Owing to the decreasing prices of RNA-seq, these experiments generated a big and growing number of time series datasets that aim to track a certain process of differentiation by taking snapshots of the gene expression at different time points. These datasets could be further analyzed to obtain a better extensive explanatory model of the regulatory processes and to identify new important regulators that can be manipulated to enhance the process. Deriving as much information as possible from such experiments is a crucial goal in the fields of medical and biological research \[[@pone.0231326.ref009]--[@pone.0231326.ref013]\], yet there is still a need for computational methods that analyze such unique models in a way tailored to their special properties.

One common challenge to the researchers in these fields is identifying a set of candidate genes that are crucial for the study case, from the thousands of genes in the dataset, that if manipulated can impact the quality and the outcome of the process under study. This candidate set has to be small enough to make the experimental validation of each candidate feasible. One approach is constructing co-expression networks, clustering the genes into modules, usually large ones, then attempting to reduce these modules based on topological feautures \[[@pone.0231326.ref014]\]. Other approaches, like Short Time-series Expression Miner (STEM), find statistically significant gene patterns and the genes associated with them \[[@pone.0231326.ref015]\]. Differential gene expression (DEG) analysis is one of the most popular methods to create lists of genes that can be stage-associated. DEG lists provide a good start but often are large in size, and the stage-specific regulators often get diluted in more general genes leading to rather general GO terms when enriched. TFRank \[[@pone.0231326.ref016]\] is a popular network-based prioritization method, but it doesn't integrate time series expression data. There are other different approaches to prioritize genes and reducing gene lists resulting from previous methods \[[@pone.0231326.ref017]\], yet none of these specifically take into account the unique properties of cell differentiation.

Another challenge lies in identifying and understanding the important regulatory interactions and programs that trigger and control the expression of different essential genes. One of the most useful and general approaches to address these regulatory programs is via constructing gene regulatory networks (GRNs), typically a directed graph with the genes as nodes and the edges connecting the nodes usually indicating the regulatory interactions. In the past years, many methods and models have been developed to construct GRNs based on either expression data \[[@pone.0231326.ref018]\], Chip-seq, binding sites analysis, or other data types and models. Some of these models depend solely on one data type to build these networks while others more effectively combine one or more data sources. Despite the general success of some methods which derive GRNs from gene expression data, they have commonly known limitations, such as the inability to deal with time series data in the case of Bayesian Networks (BNs), excessive computational time in the case of Dynamic Baysian Networks (DBNs), and the fact that the number of genes is mostly greater than the number of experimental conditions can cause problems when it comes to methods like Graphical Gaussian Models (GGMs) and BNs \[[@pone.0231326.ref019], [@pone.0231326.ref020]\]. Another different approach is using binding site analysis in the genome to predict the capability of transcription factors (TFs) to regulate the expression of target genes. TFs have the potential to bind to a DNA region via a binding site with a specific pattern of nucleotides that can be recognized by the DNA-binding domain (DBD) associated with each TF. The challenge in this approach lies mainly in finding the proper library of positional weight matrices (PWMs), the ideal thresholds, and cutoffs and defining the regions of search. The result is an extensive regulatory network that covers a large number of potential regulatory interactions. While these regulatory effects are potentially possible, only a subset of these interactions takes place in a specific context and time. Finding these subsets and refining the global regulatory network according to the biological context under study would result in a more meaningful and case-relevant network.

To tackle these challenges, we constructed a novel workflow and a model of a regulatory network that incorporates the element of time and temporal order, integrates the expression levels of genes, is concise enough to be inspected visually, and identifies candidate regulators efficiently. The method is time and memory efficient, yet it generates a model with a specific architecture to display the primary transcriptional regulators, such as TF genes and miRNAs, and regulatory events unfolding with time. It pre-computes an extensive gene regulatory network that is based on binding site analysis, is independent of the expression data and is used as a background regulatory network. The workflow then uses expression data to identify stage-specific regulators based on their expression pattern. These regulators are finally organized in a cascade architecture that we call a temporal regulatory cascade (TRC). In a TRC, master regulators specific for each stage are organized in ordered vertical columns, and potential regulatory interactions that are based on the background network are displayed as edges between these regulators. To demonstrate this model, we developed an online tool aimed for experimentalists as well as bioinformaticians interested in investigating the regulatory forces that might explain the observed expression of genes in a particular time series dataset. Our novel workflow offers the automatic generation of a TRC from an uploaded time series dataset and visualizes it in an animated interactive manner. In order to facilitate direct interpretation, the results at any stage of the workflow are distilled to an amount that can be handled and analyzed visually, keeping the top significant genes, interactions, and information and discarding those with lower significance and specificity.

In this manuscript, we describe the workflow in detail and report on its application to two time series expression datasets. Both datasets characterize the differentiation of pluripotent stem cells into mature cardiac myocytes and neural progenitors, and the corresponding TRC was generated and analyzed in each case. The main aim was to analyze the specific regulatory activity in each stage, identify and evaluate regulators specific for each time point in the differentiation process, and to test the efficiency of the workflow in re-identifying some well-known case-relevant regulators and regulatory interactions without prior knowledge.

Materials and methods {#sec002}
=====================

Background regulatory network {#sec003}
-----------------------------

A library of position weight matrices (PWMs) from TRANSFAC^®^ \[[@pone.0231326.ref021]\] is used in combination with the MATCH^™^ \[[@pone.0231326.ref022]\] program to predict transcription factor binding sites (TFBSs) in the conserved promoter regions of the human genome as follows.

Based on 49,344 RefSeq-annotated human transcription units (UCSC track refGene, Jan. 22, 2014), the -1kb upstream region was selected as a proximal promoter. The transcription start site (TSS) indicated in RefSeq was used as the reference point.

On the basis of pre-calculated whole genome alignments provided by the UCSC (46\_ WAY_MULTIZ_hg19) these promoter definitions were utilized to retrieve the sequence conserved regulatory regions between human (hg19), mouse (mm9), dog (canFam2) and cow (bosTau4). Afterwards, gaps resulting from the multiple genome alignment were removed.

MATCH was used to predict potential TFBSs in the previously identified conserved promoter regions, based on all vertebrate defined matrices using the PWM library from TRANSFAC (release 2013.1, 1446 vertebrate matrices). All matrices with default minFN threshold (minimize false negatives) were used in order to predict potential TFBSs that have at least the quality of an annotated TFBS in TRANSFAC. 1360 out of 1446 TRANSFAC-PWMs had a sequence-conserved TFBS prediction. We ranked all predicted TFBSs associated with each PWM, according to their MATCH score. We chose the best 5% predicted binding sites for each PWM and constructed the background transcriptional regulatory network accordingly. The PWMs are translated to human TF-gene names (HGNC-defined) using the TRANSFAC database. Each TF-gene, identified by its official HGNC-defined gene name, was represented as a node, with a directed edge connecting it with its target gene node. Further information about the construction of the regulatory network can be found in our previous manuscript \[[@pone.0231326.ref023]\].

The core network included 829 TFs and their 16354 targets, summing up to 749949 interactions. Another expanded network, which includes microRNA binding predictions, was constructed and contained 2239 regulators and 20160 targets. This network was computed once and is independent in the process of its derivation from the expression data, making it usable with every human expression dataset.

While the tool offers the user the option to upload a custom regulatory network to be used for the analysis, we recommend the built-in network just described. The conservation property of these sites makes the prediction ideal for the differentiation context since several pieces of research have shown that conserved regions in the DNA are critical binding sites for development and differentiation \[[@pone.0231326.ref024]--[@pone.0231326.ref027]\].

Temporal regulatory cascades (TRCs) {#sec004}
-----------------------------------

The method utilizes the concept of constructing template expression patterns that represent an expression behaviour of interest, then attracting genes that behave similarly to these patterns using correlation. The template patterns we used were stage-specific patterns, peaking at one time point only, and denoted by template peak patterns (TPPs). While different kinds of template patterns can be used, we chose the single-peak TPPs, as a default for its ability to attract stage-specific regulators that are unique to each time point. Regulatory interactions are queried from the background regulatory network and form the edges between the genes in the cascade accordingly.

### TRC construction steps {#sec005}

1.  **Step 1**: Create a library of TPPs, one TPP for each time point in the dataset. For each time point the corresponding TPP has an expression level of 100 percent at that time point and zero every other time point([Fig 1A](#pone.0231326.g001){ref-type="fig"}).

2.  **Step 2**: For each TPP, calculate the top *n* correlated regulators to this reference pattern ([Fig 1B](#pone.0231326.g001){ref-type="fig"}). These genes are said to be the stage-specific regulators of stage *s* and are displayed in the same column ([Fig 2](#pone.0231326.g002){ref-type="fig"}). If a time point has no correlated regulators, no column is created for this stage in the TRC.

3.  **Step 3**: All regulatory interactions between the regulators of the same stage are mapped, according to their connections in the background regulatory network, and represented in the form of directed edges.

4.  **Step 4**: All regulatory interactions between the regulators of stage *s* and the next stage are mapped according to their connections in the background regulatory network and represented by directed edges, linking each stage to the next and tying the cascade together ([Fig 2](#pone.0231326.g002){ref-type="fig"}).

![Indetifying stage-specific regulators.\
(A) The TPP of T2: The template peaking pattern is calculated where the expression is at 100 percent T2 and zero every other timepoint. One TPP for each time point is calculated similarly and the collection of these TPPs form the TPP library. (B) Top 10 regulators that are highly correlated with the previous TPP of T2 and their noticeable T2-specific peaking pattern, these regulators will form nodes in the T2 column in the TRC, the same is done for every TPP in the library.](pone.0231326.g001){#pone.0231326.g001}

![The TRC workflow.\
Regulators specific for each time point are grouped in the same column with the same color and sorted by their correlation to the TPP of that stage. The edges between the two stages and within the same stage are retrieved and mapped from the regulatory network.](pone.0231326.g002){#pone.0231326.g002}

### Parameters {#sec006}

To adjust the temporal regulatory cascade, we use three primary parameters:

1.  *minE*: A threshold for gene expression levels. A gene that does not have an expression level higher than this threshold in any of the replicates or time points is eliminated and omitted from the calculation that leads to the TRC. This eliminates peaking genes that are lowly expressed even at their peak.

2.  *minC*: A minimum correlation threshold. Regulatory genes that have a correlation above this threshold to the TPP of a stage are kept as the initial set of regulators associated with that stage.

3.  *maxS*: The maximum number of genes that can be associated with a specific time point. The initial regulators associated with a time point based on *minC* are sorted by their correlation to the TPP of that stage, and the top *n* (*maxS*) regulators are picked to be in the column associated with the stage. If the initial regulators set has less than *maxS* genes, then the whole set is taken. The max number of nodes in the cascade is *maxS* multiplied by the number of time points.

Implementation {#sec007}
--------------

This workflow was implemented in the form of a web service with an interactive visual web interface, which eliminates then the need to install any additional software. The algorithm to generate the TRCs was implemented using Java. In order to display the resulting TRC, a visualizer was implemented using JavaScript, utilizing, and extending the Cytoscape library cy.js. The framework used PHP to manage the files and sessions. The visualizer was embedded in an interactive webpage that includes helpful information such as graphs of the expression levels of the genes in the cascade, tables, and metrics, in addition to direct links to perform GO enrichment and other workflows in the platform. The web tool is a part of a more comprehensive web service that revolves around gene regulation and expression data analysis that is under construction.

Data {#sec008}
----

While any formatted time series data can be used as input, this model performs the best with RNA-Seq data over other sources of inferior quality and less variability such as microarray data. Normalized input data provides a better quality TRC, nevertheless even using the raw counts leads to reasonably significant TRCs. As study cases to demonstrate the TRC model, two time series gene expression datasets were used and denoted Dataset1 and Dataset2.

Dataset1 was assembled using public RNA-Seq data that is captured during the differentiation of H1 derived human neuronal precursor cells (NPCs) across the days 0,1,2,4,5,11, and 18 after induction of neuronal differentiation. Publicly available DEG and GO enrichment analysis on the same dataset was used for comparison. The dataset and the analysis results could be found in the expression Atlas under the accession E-GEOD-56785. The assembled and formatted data can be found in [S1 File](#pone.0231326.s001){ref-type="supplementary-material"}.

Dataset2 was derived from the normalized expression datasets from the previously published study by Qing Liu et al \[[@pone.0231326.ref028]\], publicly available in the GEO repository under the accession number GSE85332. We chose one of the four expression datasets available, the RNA-Seq profiling of the differentiation of C20 derived cardiomyocytes at four stages: pluripotent stem cells (day 0), mesoderm (day 2), cardiac mesoderm (day 4), and differentiated cardiomyocytes (day 30). The assembled and formatted data can be found in [S2 File](#pone.0231326.s002){ref-type="supplementary-material"}.

GO enrichment {#sec009}
-------------

To evaluate the relevance of the gene sets in each stage, Gene Ontology (GO) enrichment analysis using the biological processes and a Fisher's Exact test on each column in these cascades was applied using one set at a time as an input. Terms that have a pvalue less than 0.05 after the Bonferroni correction are sorted by their fold enrichment and the top terms were examined. These terms were evaluated based on their consistency with the differentiation stage under observation at that time point.

Results {#sec010}
=======

We applied the TRC workflow to Dataset1 and Dataset2 and generated a cascade for each study case. In addition to the GO enrichment, detailed literature research was performed, investigating the roles of the different regulators predicted by the cascade.

Neural differentiation cascade {#sec011}
------------------------------

Upon the visual inspection of the cascade, we observe a missing time point that is day 2, indicating that this time point does not have any peak strength or any genes that exceed the correlation threshold to the TPP, suggesting that day 2 might be a time point that doesn't underly any unique stage-specific activity ([Fig 3](#pone.0231326.g003){ref-type="fig"}).

![Neural differentiation cascade.\
The TRC generated for the differentiation of neural proginators based on dataset 1 and the following parameters: *minC = 0.6*, *minE = 4*, and *maxS = 10*.](pone.0231326.g003){#pone.0231326.g003}

Examining the GO enrichment of each time point reveals high enrichment of relevant terms in day 1 and day 11. Regulators of day 1 showed enrichment for specific terms such as cell and neuron fate commitment, neuron differentiation, and cell differentiation in the spinal cord. Regulators of day 11 showed high enrichment of even more specific terms such as spinal cord association neuron differentiation, dorsal spinal cord development, cell fate determination, cell differentiation in the spinal cord, hindbrain development. On the other hand, examining the GO enrichment based on the DEG analysis publicly available for the same dataset, differentially expressed genes in day 0 vs. day 1 and day 0 vs. day 11 showed no significant enrichment of specific terms associated with neural development but rather more general terms.

A deeper look into the identity of the regulators in the cascade shows that *OLIG1* and *OLIG3*, which are known for their importance in neural and spinal development \[[@pone.0231326.ref029]--[@pone.0231326.ref031]\], are active in day 1, suggesting that their importance lies in the earlier part of the differentiation. A microRNA *MIR3659* peaking at day 1 with a high indegree raises the question on the nature of its involvement in neural differentiation, which needs to be further investigated. *PAX2* on day 11, with the highest outdegree, regulates 13 different regulators in the same and next time point which hints that its known essential role in neural development \[[@pone.0231326.ref032]--[@pone.0231326.ref034]\] is due to its regulatory impact on a big set of neural regulators. *KLF2* in day 5 stands out as a potential significant regulator of the day 11 regulatory wave due to its potential ability to regulate a big portion of day 11 regulators. The TRC shows an overall same-stage presence of certain TFs that belong to the same family or subfamily according to the classification experimental conditions TFs in TFClass \[[@pone.0231326.ref035], [@pone.0231326.ref036]\], such as *OLIG1*, *OLIG3* and *BHLHE23* in day 1, *STAT1* and *STAT6* in day 5, the *LHX1* and *LHX5* in day 11, *DBX1* and *DBX2* in day 18. A hypothesis can be made that these TFs are part of the redundancy that leads to the robustness of such regulatory programs, or that these families and subfamilies of TFs collaborate in certain regulatory stages.

Cardiac differentiation cascade {#sec012}
-------------------------------

Regulators of the first time point show enrichment of terms related to stem cell maintenance, which is coherent with the biological context since the process of differentiation has not started yet, and the cells are still in the induced stem cell state ([Fig 4](#pone.0231326.g004){ref-type="fig"}). These regulators could be essential for maintaining the pluripotency state and also could be repressing differentiation. Regulators of day 2 show enrichment of terms associated with mesenchymal and mesoderm morphogenesis, which give rise to cardiac cells. Regulators of the last stage the cardiomyocyte (CM) stage show high enrichment of heart-specific terms such as cardiac ventricle and chamber formation, ventricular cardiac muscle differentiation, heart looping, and outflow tract morphogenesis. These terms show a high consistency with the underlying stage of differentiation reported by the experiment.

![Cardiac differentiation cascade.\
The TRC generated for the differentiation of cardiomyocytes based on dataset2 and the following parameters: *minC = 0.6*, *minE = 30*, and *maxS = 12*.](pone.0231326.g004){#pone.0231326.g004}

In the first time point TFs associated with maintanining the pluripotency state like *NANOG* \[[@pone.0231326.ref037]\], *PARP1* \[[@pone.0231326.ref038]\], *SOX2* \[[@pone.0231326.ref039]\], *MYC* \[[@pone.0231326.ref040], [@pone.0231326.ref041]\], *ETV4* and *ETV5* \[[@pone.0231326.ref042]\] appear. *CDX1* and *CDX2* \[[@pone.0231326.ref043]\] which are known to modulate early cardiogenesis peak at day 2, alongside some potentially important early cardiac regulators such as *TCF4* and *LEF1*. On day 4, *MYCN* stands out with a high outdegree and indegree confirming its known role in heart development \[[@pone.0231326.ref044]\] along side with some potential candidate regulators such as *LHX1*, *OTX2*, *NR2C1*, *MIR548Y*. The last stage where the cardiomyocytes have already matured, features core regulators essential for cardiac development such as *MEF2C* \[[@pone.0231326.ref045]\], *HAND2* \[[@pone.0231326.ref046]\], *NKX2-5* \[[@pone.0231326.ref047]\], *MEIS2* \[[@pone.0231326.ref048]\], *MITF* \[[@pone.0231326.ref049]\], FOXP1 \[[@pone.0231326.ref050]\] and some new candidate regulators that could be significant in the cardiac maturation such as *MEF2A* and *BHLHE40*. Like in the previous dataset, a strong same-stage presence of certain TF family members is observed, such as the members of the HOX family CDX1, CDX2, HOXA1 and HOXB1 in day 2.

Discussion {#sec013}
==========

Unlike some of the classic regulatory models such as BNs, the TRC model takes advantage of the sequential order of the time series data to allow more intricate interpretations of regulatory interactions. It takes advantage of the emerging property from the peaking patterns, that is: each node in the cascade is positively correlated in its expression pattern to the other nodes in the same stage ([Fig 5A](#pone.0231326.g005){ref-type="fig"}), and correlated via a time-lagged correlation to the nodes in the other stages ([Fig 5C](#pone.0231326.g005){ref-type="fig"}). Thus each edge in the cascade is always coupled with a correlation between the expression pattern of the regulator and its target. This coupling can be viewed as a reinforcement of the regulatory interaction predictive quality and gives it an edge over interactions based solely on the binding site analysis or solely derived from gene expression data. From another view, the binding site prediction behind the edge can explain the perceived correlation in the expression patterns between the target and the source. [Fig 5](#pone.0231326.g005){ref-type="fig"} summarizes the five common types of regulatory interactions displayed within the cascade through edge patterns. [Fig 5A](#pone.0231326.g005){ref-type="fig"} is an example of a regulatory interaction coupled with high positive correlation indicating that X is potentially one of the activators of Y and contributes to its peaking pattern. Y is inactive where X is inactive and activated when X is activated (stage i), coupled with the fact that X can bind to the promoter of Y, this hypothesis of the regulatory influence of X on Y is strongly enforced. [Fig 5A](#pone.0231326.g005){ref-type="fig"} has a one-direction property that supports the causality, whereas cases such as the double edge displayed in [Fig 5B](#pone.0231326.g005){ref-type="fig"} cannot decisively assert whether X is an activator of Y or the other way around due to the non-causal nature of correlation and the double potential of these regulators to bind to each other's promoters. [Fig 5C](#pone.0231326.g005){ref-type="fig"} is an example of where a regulator in a certain stage potentially needs more time to activate the target thus the target is activated after a time delay and captured in the next stage. This kind of regulatory behavior has been shown and captured using time-lagged correlation models. Another common hypothesis that surrounds co-expressed genes is that they might be coregulated by a master regulator or a set of master regulators. Some of these master regulators can be captured through configurations in the cascade where a regulator emerging in a stage single-handedly has the potential to activate a wide set of correlated regulators, whether in the same stage as in the case of [Fig 5D](#pone.0231326.g005){ref-type="fig"} or a set of targets in the next stage via a time-lagged regulation as shown in [Fig 5E](#pone.0231326.g005){ref-type="fig"}.

![Different cases of regulatory interactions contained in the TRC model.\
(A) A one-way regulatory prediction within one stage coupled with a high positive correlation. (B) A two-way regulatory prediction within one stage coupled with a high positive correlation. (C) A regulatory interaction from one stage to the next, coupled with a high positive time-lagged correlation. (D) X a potential master regulator of X, Y, and Z coupled with a high positive correlation to each of its targets. (E) X a potential master regulator activating X, Y and Z coupled with a high positive time-lagged correlation to each of its targets.](pone.0231326.g005){#pone.0231326.g005}

The previous analyses of the two datasets showed clear stage-specific regulatory waves and a GO enrichment that is highly consistent with the biological context of the experiment and, even more specifically, the context in the particular time points of the experiment. The question arises whether these peaking profiles and case-specific GO enrichments are statistically significant, and constitute a characteristic of developmental gene expression datasets in particular, or if they randomly occur in any dataset. While applying the TRC model to a sufficiently large number of random and shuffled datasets and evaluating the resulting TRCs would be optimal to proof the statistical significance of the results, it is merely unfeasible due to the manual process of assessing the resulting TRCs. Alternatively, we applied the model to randomly generated and shuffled gene expression datasets (see the supplementary files) aiming towards a comparative analysis rather than a statistical proof of significance. We examined the resulting TRCs in terms of the GO enrichment of the stages to evaluate their relevance compared to a TRC generated from a real experimental dataset. The first test involved shuffling dataset2 by re-assigning genes to other expression profiles ([S3 File](#pone.0231326.s003){ref-type="supplementary-material"}), to check whether any set of peaking regulators will show a specific GO enrichment, and none of the stages did lead to any relevant terms. The test was repeated by shuffling the regulator's profiles only, and the enrichment was again insignificant. The previous test showed that the identity of the peaking genes is essential, precise, and specific. Moreover, the workflow was applied to dataset2 without restricting the stage-specific sets to regulators only. Interestingly, the generated cascade was overwhelmed by non-regulatory genes and the GO enrichment showed no significant terms in any of the stages, with the exception of two terms related to cardiac muscle differentiation in the last stage ([S1 Fig](#pone.0231326.s006){ref-type="supplementary-material"}). This observation supports the choice in the TRC model of limiting the cascade to regulators where less relevant non-regulatory genes do not dilute the small stage-specific gene sets. Next, dataset2 was shuffled by permuting all the values in the expression matrix ([S4 File](#pone.0231326.s004){ref-type="supplementary-material"}). The result was again a lack of significance in GO the enrichment terms. The last test was applying the TRC workflow to a randomly generated gene expression dataset, using the gene names and the time points from dataset2 combined with randomly generated expression values ([S5 File](#pone.0231326.s005){ref-type="supplementary-material"}). The GO enrichment showed the absence of any relevant significant terms again.

The default library used in this model is the one-stage peak pattern library, which works optimally with development and differentiation. However this library can be changed, and multiple libraries for different biological contexts such as diseases and immune responses can be developed accordingly, which would require further research or alternatively allowing the user to construct a custom library in the future.

One drawback of this model is the fact that it does not capture every important regulator, particularly those regulators that are expressed in multiple consecutive or non-consecutive time points. However, we argue that the sets of regulators identified by the cascade contain a large percentage of essential stage-specific regulators which is supported by the GO enrichment. On the other hand, the regulatory network might not cover every TF due to missing PWM information or lack of conservation. Another more general drawback is the fact that the model relies on transcript levels which do not translate directly into protein levels, but relative measures \[[@pone.0231326.ref051]\] \[[@pone.0231326.ref052]\] can be a potential method for further analysis whenever protein data is not available. Moreover, the candidate regulators can provide a small concise set for a proteomic investigation as a next step in the experiment. The captured regulators can also provide a starting point for further analysis such as target set enrichment analysis, pathway analysis, and investigating the potential collaboration of regulators using tools such as PC-Traff \[[@pone.0231326.ref053]\]. The TRC model merely lays down, in place, some important starting pieces that can be built on to complete the biological puzzle of developmental regulatory programs.

The unique type of the output of the TRC makes it difficult to accurately compare it to other existing methods, as no other method has the same definition of a regulatory cascade. However, we utilized the context-relevance of the GO enrichment of the gene sets predicted by other methods as a basis for the comparison. We first applied the STEM in order to predict the top 10 significant gene expression patterns in the cardiac differentiation dataset and evaluated the GO enrichment of the genes set associated with each of these profiles. The GO enrichment of these sets showed very general terms not specific to the cardiac differentiation context. Next, we applied iDREM \[[@pone.0231326.ref054]\], which we consider the closest method to the TRC in terms of inputs and aims, using the cardiac differentiation dataset and the regulatory network provided by iDREM (human_predicted_1000), to generate a dynamic regulatory network. The resulting model was in the form of a dynamic regulatory map that highlights major bifurcation events, each of which has a list of associated regulatory genes. The GO enrichment of these gene lists showed a mild enrichment of developmental GO terms in some bifurcation points and no enrichment in most of the others. However, proving the validity of a generated network or cascade requires an actual experimental validation of the predicted regulatory interactions in the particular cellular context, which is currently unpractical.

This workflow is built within a broader framework dedicated to studying regulation from different points of view. It blends expression data and a regulatory network and links concepts such as coexpression and coregulation forming a more extensive tool. Users can interactively investigate different hypothesis and track different genes and regulators of interest exploring the regulatory forces governing the time series data, the timing of such forces and the impact of such regulatory interactions on the expression of genes and regulators.

Conclusion {#sec014}
==========

We developed a workflow to analyze and represent regulatory cascades and a web tool based on the corresponding model. It takes time series expression data as an input, generates and visualizes an interactive cascade that identifies relevant and stage-specific regulators associated with each time point and the interactions between these regulators. The workflow was applied to multiple datasets that revolved around cell differentiation and was successful in identifying previously-known TFs relevant to the time points and the cell types, in addition to some new candidate regulators, as well as pinpointing the time points were unique regulation activities are emerging. A demo of the web tool is available under TF-investigator.sybig.de/TRC.

Supporting information {#sec015}
======================

###### NPC differentiation (Dataset1).

The formatted data expression file based on human H1-derived NPC differentiation differentiation. This format is ready for upload via the webtool.

(CSV)

###### 

Click here for additional data file.

###### Cardiac differentiation (Dataset2).

The formatted data expression file based on C20 derived cardiomyocyte differentiation. This format is ready for upload via the webtool.

(CSV)

###### 

Click here for additional data file.

###### Shuffled profile assignment of dataset2.

A version of dataset2 where gene profiles are randomly re-assigned. This format is ready for upload via the webtool.

(CSV)

###### 

Click here for additional data file.

###### Shuffled dataset2 by permuting the matrix.

A version of dataset2 where cells in the expression matrix are permuted across columns and rows. This format is ready for upload via the webtool.

(CSV)

###### 

Click here for additional data file.

###### Random expression values with dataset2 time points and gene names.

Random expression values with time points and gene names taken from dataset2. This format is ready for upload via the webtool.

(CSV)

###### 

Click here for additional data file.

###### TRC based on dataset2 where regulatory and non-regulatory genes are included.

Stage-specific gene sets are not restricted to regulators in this example. This allows the TRC to include peaking non regulatory genes as well.

(TIF)

###### 

Click here for additional data file.
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A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Roberto Mantovani

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. Please upload a new copy of Figure 1 as the detail is not clear.

Please follow the link for more information: [http://blogs.PLOS.org/everyone/2011/05/10/how-to-check-your-manuscript-image-quality-in-editorial-manager/](http://blogs.plos.org/everyone/2011/05/10/how-to-check-your-manuscript-image-quality-in-editorial-manager/)

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: N/A

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The authors propose a novel approach to explore time-series gene expression data, integrating them with the underlying regulatory network. The idea of identifying time-point-specific regulators candidates from the expression profiles and then mapping them back to a background regulatory network in order to figure out temporal relationships and identify a small set of key regulators for each time-point is surely worth to be investigated. The two examples reported by the authors are also interesting, but perhaps a more comprehensive selection of use cases could add strength to the manuscript. A comparison with other tools to investigate temporal regulatory cascades would also be interesting. Unluckily, the implementation of the user front-end to the method and of the documentation seems still in a very preliminary phase, and this needs to be addressed before publication. Also, the methods used to draw the regulatory network could be somewhat refined.

Major:

\- The design of the gene regulatory network is of fundamental importance for this method, but this aspect seems to be a bit overlooked in the manuscript. In particular additional discussion and implementation efforts should be devoted to:

\--how is a promoter defined?

\--Why only are Transfac PWMs used when there exist other libraries like Jaspar, with the additional advantage that they are not commercial?

\--The PWM score threshold method to associate a TF to a given promoter is very blunt and could be refined. In any case, how is the threshold chosen? A simple reference to another paper is not sufficient for a matter of this importance for this method.

\-- Why selecting mammals specific conserved regions (human, mouse, dog, and cow) genomes works better than regions conserved among vertebrates instead? Would it be possible, for example, to identify mammal-specific regulators comparing the results obtained with networks built using vertebrate conserved regulatory regions instead of mammals ones?

\-- On the other hand, would it be possible to rely on chromatin states instead of conservation in order to identify functional promoter regions and how the results would change?

\- A comparison of results with other methods for temporal gene networks adopting other approaches could help readers and potential users in understanding the advantages of this method. For example, the cascade R package \[Jung et al.\] could be used as a benchmark.

\- The Neural and Cardyomyocytes examples reported by the authors are suggestive, but a somewhat more extensive selection of examples could be helpful. In particular, it would be interesting to see if the method can be applied with success also to non-human time series. For example, an interesting dataset could be the time-resolved transcriptome of C. elegans \[Boeck et al.\]. PWMs for C. elegans are also available in Jaspar.

\- This is the weakest point of the manuscript. The implementation of the method is not usable in its current state. At the link that has been provided, there is a very blunt interface without any documentation. No information, for example, is provided on the format of the input file, no license, no terms of use, no tutorial or explanation on how to use it, and understand the output. If this is open software, it should be made available using standard repositories. There is no way to select the background regulatory network to be used, so it seems to works only for human data using the default background regulatory network built by the authors, but it would be much better to provide more topologies to users and maybe also let users provide their topologies.
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6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Responses to editor's comments:

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at:

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

We adjusted the names of the supplementary data files from "S.. Dataset" to "S.. File" and "S1 Figure" to "S1 Fig.". We hope that it now fits the style requirements, as described in the referred templates.

2\. Please upload a new copy of Figure 1 as the detail is not clear.

As pointed, Figure 1 was not clear, mainly because of the amount of information that rendered the details hard to read. So we decided to substitute the figure with two new separate figures Figure 1 and Figure 2. The manuscript was adjusted accordingly.

 

Responses to reviewer \#1:

The design of the gene regulatory network is of fundamental importance for this method, but this aspect seems to be a bit overlooked in the manuscript.

We agree with the reviewer on the importance of the design of the gene regulatory network (GRN) used. However, since the focus of the present paper was on the construction of regulatory time cascades, which can be done on the basis of any GRN, we intentionally cut this aspect short. Including all technical details of its construction would also require more detailed considerations of data sources used, algorithms used for the detection of transcription factor binding sites, thresholds applied, etc. The network we constructed, described previously and used in a number of studies consistently proved functional. Its construction was a considerable effort, and to re-do this with another data source would preclude a timely publication of the results described in our paper without adding to its main points. As said, the method described can be applied using any other GRN; however, as suggested by the reviewer, we added the possibility for users to exchange the precomputed GRN by a customized one in case the user has one at hand . Of course, the results may differ. We expanded the background regulatory network section in the materials and methods to include the details of the construction of the network.

To address the questions raised by Reviewer \#1 in more detail:

\--how is a promoter defined?

Based on 49,344 RefSeq-annotated human transcription units (UCSC track refGene, Jan. 22, 2014), the -1kb upstream region was selected as a proximal promoter. The transcription start site (TSS) indicated in RefSeq was used as the reference point.

On the basis of pre-calculated whole-genome alignments provided by the UCSC (46\_ WAY_MULTIZ_hg19) these promoter definitions were utilized to retrieve the sequence conserved regulatory regions between human (hg19), mouse (mm9), dog (canFam2) and cow (bosTau4). Afterward, gaps resulting from the multiple genome alignment were removed.

\--Why only are Transfac PWMs used when there exist other libraries like Jaspar, with the additional advantage that they are not commercial?

TRANSFAC has been the first database about gene regulatory components and binding site models (PWMs) and still is the most comprehensive data source for these entities, also comprising the Jaspar collection.

\--The PWM score threshold method to associate a TF to a given promoter is very blunt and could be refined. In any case, how is the threshold chosen? A simple reference to another paper is not sufficient for a matter of this importance for this method.

MATCH was used to predict potential TFBSs in the previously identified conserved promoter regions, based on all vertebrate defined matrices using the PWM library from TRANSFAC (release 2013.1, 1446 vertebrate matrices) . All matrices with default minFN threshold (minimize false negatives) were used in order to predict potential TFBSs that have at least the quality of an annotated TFBS in TRANSFAC. 1360 out of 1446 TRANSFAC-PWMs had a sequence-conserved TFBS prediction. We ranked all predicted TFBSs associated with each PWM, according to their MATCH score. We chose the best 5% predicted binding sites for each PWM and constructed the background transcriptional regulatory network accordingly. The PWMs are translated to human TF-gene names (HGNC-defined) using the TRANSFAC database. Each TF-gene, identified by its official HGNC-defined gene name, was represented as a node, with a directed edge connecting it with its target gene node.

\-- Why selecting mammals specific conserved regions (human, mouse, dog, and cow) genomes works better than regions conserved among vertebrates instead? Would it be possible, for example, to identify mammal-specific regulators comparing the results obtained with networks built using vertebrate conserved regulatory regions instead of mammals ones?

This is certainly a valid suggestion by Reviewer \#1, but identifying mammal-specific regulators was not in the scope of our study. When extending conservation to non-mammalian genomes, the number of conserved binding sites would drop considerably and would not help in interpreting, as in this study, human data. On the other side, including monkey or rat would not add since they are too close to human and mouse, resp.

\-- On the other hand, would it be possible to rely on chromatin states instead of conservation in order to identify functional promoter regions and how the results would change?

Since chromatin states are highly dependent on the cellular context, corresponding data would always refer to individual cells / cell lines only and would not help in constructing a comprehensive GRN.

\- A comparison of results with other methods for temporal gene networks adopting other approaches could help readers and potential users in understanding the advantages of this method. For example, the cascade R package \[Jung et al.\] could be used as a benchmark.

The unique type of the output of the TRC makes it difficult to accurately compare it to other existing methods, as no other method has the same definition of a regulatory cascade. However, we utilized the context-relevance of the GO enrichment of the gene sets predicted by other methods as a benchmark for the comparison. We considered the suggested Cascade R package for the comparison however we felt it was not properly maintained and subsequently, we couldn\'t manage to run it on the required dataset, and more importantly we needed a method that also combines some sort of a precomputed regulatory network to make the comparison fair. To compare our suggested template profiles to other profile possibilities, we first applied the STEM in order to predict the top 10 significant gene expression patterns in the cardiac differentiation dataset and evaluated the GO enrichment of the genes set associated with each of these profiles.The GO enrichment of these sets showed very general terms not specific to the cardiac differentiation context. Next, we applied iDREM, which we consider the closest method to the TRC in terms of inputs and aims, using the cardiac differentiation dataset and the regulatory network provided by iDREM (human¬ predicted¬1000), to generate a dynamic regulatory network. The resulting model was in the form of a dynamic regulatory map that highlights major bifurcation events, each of which has a list of associated regulatory genes. The GO enrichment of these gene lists showed a mild enrichment of developmental GO terms in some bifurcation points and no enrichment in most of the others. However, proving the validity of a generated network or cascade requires an actual experimental validation of the predicted regulatory interactions in the particular cellular context, which is currently unpractical. We added a paragraph in the discussion section of the manuscript, where we address the comparison part just discussed.

\- The Neural and Cardyomyocytes examples reported by the authors are suggestive, but a somewhat more extensive selection of examples could be helpful. In particular, it would be interesting to see if the method can be applied with success also to non-human time series. For example, an interesting dataset could be the time-resolved transcriptome of C. elegans \[Boeck et al.\]. PWMs for C. elegans are also available in Jaspar.

The GRN constructed was specifically designed to support the reliable interpretation of mammalian, in particular human gene expression time series for biomedical research. Analyzing non-mammalian data would require a different GRN, as well as specific expertise and field of focus related to that species. We chose those examples where the validation of the results on the basis of existing knowledge was possible. However, with the added option of uploading their own regulatory network, the users can now explore different expression datasets and networks related to other species.

\- This is the weakest point of the manuscript. The implementation of the method is not usable in its current state. At the link that has been provided, there is a very blunt interface without any documentation. No information, for example, is provided on the format of the input file, no license, no terms of use, no tutorial or explanation on how to use it, and understand the output. If this is open software, it should be made available using standard repositories. There is no way to select the background regulatory network to be used, so it seems to works only for human data using the default background regulatory network built by the authors, but it would be much better to provide more topologies to users and maybe also let users provide their topologies.

We agree with the reviewer's points, and thus we adjusted the implementation of the webtool accordingly. We added a manual that explains, for example, the file formats and the underlying methods, workflows, and parameters. We also added a tutorial section as well as help buttons and icons that are intended to guide the user through webtool. And most importantly, we added the option that allows the user to upload his own regulatory network as well and use it as a background network for the analysis.

We also added supportive workflows, which we had in mind from the beginning; these workflows such as the co-expression analysis are not novel in their methodology and are based on classic methods. Thus we did not go into the description of these workflows in the paper, keeping the focus in the novel TRC method; however, in the manual , a detailed description of these workflows can be found. This creates an exploratory platform where a user can further explore different aspects of regulation and gene expression analysis. For this manuscript, the relevant workflow would be the "TRC analysis" workflow which can be found as the first option in the workflows page that appears after the user uploads his data or uses the sample data or built-in network. After choosing the TRC analysis workflow, the user is forwarded to a page where the parameters are adjusted accordingly.

Thank you again for your time and effort,

Best regards

Rayan Daou

###### 

Submitted filename: Response to reviewers.pdf

###### 

Click here for additional data file.

10.1371/journal.pone.0231326.r003

Decision Letter 1

Mantovani

Roberto

Academic Editor

© 2020 Roberto Mantovani

2020

Roberto Mantovani

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

23 Mar 2020

Constructing temporal regulatory cascades in the context of development and cell differentiation

PONE-D-19-28215R1

Dear Dr. Daou,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.
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Roberto Mantovani
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Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)
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If you choose "no", your identity will remain anonymous but your review may still be made public.
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